Cargando…
Our experience in three coronary patients with heparin induced thrombocytopenia type II, platelets
Autores principales: | Mikić, A, Velinović, M, Vraneš, M, Karan, R, Savić, N, Nikolić, B, Jovičić, V, Čubrilo, M, Aleksić, N, Šamanović, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846364/ http://dx.doi.org/10.1186/1749-8090-8-S1-P77 |
Ejemplares similares
-
Cell saver efficacy for coronary artery bypass surgery
por: Jovicic, V, et al.
Publicado: (2013) -
Minithoracotomy as a primary alternative for LV lead implantation during coronary resynchronization therapy
por: Putnik, S, et al.
Publicado: (2013) -
The Gender Impact on Morphogenetic Variability in Coronary Artery Disease: A Preliminary Study
por: Karan, Radmila, et al.
Publicado: (2018) -
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022) -
Heparin-induced Thrombocytopenia in Acute Coronary Syndrome
por: Kumar, Naresh, et al.
Publicado: (2019)